Drug
Salbutamol
Salbutamol: highest development phase Phase 3, developed by Chiesi Farmaceutici, Merck. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Chiesi Farmaceutici, Merck
Trials
| Drug | Phase | Indication |
|---|---|---|
| Salbutamol NCT00861926 | Phase 3 | Asthma |
| Salbutamol NCT02542254 | Phase 2 | Chronic Obstructive Pulmonary Disease |
Latest
No recent events.
Follow Salbutamol on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.